Increased sodium tolerance 1 homolog pseudogene

This molecule is a pseudogene related to the increased sodium tolerance 1 gene. Pseudogenes are non-functional genomic sequences similar to known genes but contain disabling mutations (such as frameshifts or premature stop codons), preventing them from coding functional proteins. Most pseudogenes in the human genome—including "increased sodium tolerance 1 homolog pseudogene"—are believed to lack clear biological roles or disease associations, particularly in the context of drug targeting or biomarker use. However, some pseudogenes may show partial transcriptional activity or regulatory potential, although there is no specific evidence of function or clinical relevance for ENSG00000267422[1][2][3]. Key points supporting this assessment: - "Pseudogene" is a molecular classification distinct from protein-coding genes; it is not considered a therapeutic target class such as a receptor or enzyme[1][3]. - Pseudogenes by definition have no protein product due to the accumulation of disabling mutations[1][3]. - There is no evidence that this specific pseudogene encodes a functional protein or participates in processes relevant to disease or pharmacology[1][3]. - The GENCODE and Ensembl biotype classification confirm that such pseudogenes are catalogued as "other" and separated from classical functional genes[3]. - Some pseudogenes may be transcribed or exhibit markers of partial genomic activity, but the vast majority lack well-defined function, and there is no reason to consider them direct therapeutic targets for drug development, especially when specific functional or regulatory activity is unknown or unsupported[1][2]. This entry should not be considered a conventional or actionable molecule/receptor target for drug discovery, biomarker development, or disease association studies.